Christopher L. Taylor
Direttore Tecnico/Scientifico/R&S presso Vista Therapeutics, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Spencer W. Farr | M | - |
Vista Therapeutics, Inc.
 Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | 17 anni |
| John W. Elling | M | - |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | - |
| Ronald Dennis Salesky | M | - |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | - |
| Charles Call | M | - |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 4 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Christopher L. Taylor
- Contatti personali